Fellow's Publications

Abstracts

2019

  1. Sakshi Jasra, MD, Orsi Giricz, PhD, Rachel Zeig-Owens, M.P.H, David Goldfarb, M.P.H, Angelica Barreto-Galvez, Kith Pradhan, PhD, Jiahao Chen, PhD, Gaurav S Choudhary, PhD, Srinivas Aluri, Tushar D Bhagat, PhD, Aditi Shastri, MD, Victor Thiruthuvanathan, M.S, Hiroki Goto, MD PhD, Jeannine Gerhardt, PhD, Shanisha Gordon, Arul Veerappan, PhD, Syed Hissam Haider, MD, Matthias Bartenstein, MD, George Nwankwo, Ola Landgren, MD PhD, Michael Weiden, MD, Frederick Fletcher, Lee Greenberger, PhD, Benjamin L. Ebert, MD PhD, Ulrich G. Steidl, MD PhD, Britta Will, PhD, Anna Nolan, MD MS, David Prezant, MD, Advaitha Madireddy, PhD, Amit Verma, MBBS; High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster. Blood. 2019; 134Supplement_11551 doi: https://doi.org/10.1182/blood-2019-131107
  2. R. Alejandro Sica, MD, Nishi Shah, MBBS, MPH, Ana Acuna-Villaorduna, MD, Nivetha Vishnuvardan, MD, Urvi A Shah, MD, Diego Adrianzen Herrera, MD, Alyssa De Castro, PharmD, Jennat Mustafa, PA-C, Amanda Lombardo, PA-C, BS, MS, Fariha Khatun, PA-C, Latoya Townsend Nugent, NP, Yanhua Wang, MD PhD, Olga Derman, MD, Noah Kornblum, MD, Ioannis Mantzaris, MD MS, Lizamarie Bachier-Rodriguez, MD, Aditi Shastri, MD, Kira Gritsman, MD PhD, Ulrich G. Steidl, MD PhD, Ira Braunschweig, MD, Amit Verma, MBBS, Murali Janakiram, MD MS, B. Hilda Ye, PhD; Conventional Chemotherapy Treatment Induces Unique Patterns of Clonal Evolution in a North American Adult T Cell Leukemia/Lymphoma Cohort. Blood. 2019; 134Supplement_11551 doi: https://doi.org/10.1182/blood-2019-131107.
  3. Nora E Rahmani, MD, Nandini Ramachandra, Tushar D Bhagat, PhD, Shanisha Gordon, Kith Pradhan, PhD, Bianca Rivera Pena, Mohammad Kazemi, Orsi Giricz, PhD, Shahina Maqbool, Raul Olea, Hamid Dolatshad, Vickram Tittrea, Dharamveer Tatwavedi, Shalini Singh, Andrea Pellagatti, Jacqueline Boultwood, Amit Verma, MBBS; ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation Alterations. Blood. 2019; 134Supplement_12989 doi: https://doi.org/10.1182/blood-2019-126850.
  4. Gaurav S Choudhary, PhD, Molly A Smith, PhD, Andrea Pellagatti, Tushar D Bhagat, PhD, Shanisha Gordon, Sanjay Pandey, PhD, Nishi Shah, MBBS, MPH, Srinivas Aluri, Robert N Booher, PhD, Murali Ramachandra, PhD, Maria Elena Samson, Kith Pradhan, PhD, Teresa V. Bowman, PhD, Manoj M Pillai, MD, Chandan Guha, MBBS, Amittha Wickrema, PhD, Britta Will, PhD, Aditi Shastri, MD, Ulrich G. Steidl, MD PhD, Jacqueline Boultwood, Daniel T. Starczynowski, PhD, Amit Verma, MBBS. SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AML. Blood. 2019; 134Supplement_14224 doi: https://doi.org/10.1182/blood-2019-124458.
  5. Srinivas Aluri, Kimo Bachiashvili, MD, Anjali Budhathoki, MD, Tushar D Bhagat, PhD, Gaurav S Choudhary, PhD, Shanisha Gordon, Nandini Ramachandra, Kith Pradhan, PhD, Shahina Maqbool, Aditi Shastri, MD, Jung Im Huh, Sunjin Hwang, Kim Seong-Jin, PhD, Hui Zhang, Britta Will, PhD, Amittha Wickrema, PhD, Ulrich G. Steidl, MD PhD, Amit Verma, MBBS; Clinical ALK5 Inhibitor, Vactosertib, Reverses TGFβ-1 Stimulated Smad-2 Driven Ineffective Hematopoiesis in MDS. Blood. 2019; 134Supplement_12990 doi: https://doi.org/10.1182/blood-2019-127561.
  6. Nishi Shah, MBBS, MPH, Mohammad Kazemi, Stephen Zachary Peeke, MD, Lizamarie Bachier-rodriguez, R.Alejandro Sica, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Aditi Shastri, MD, Amit Verma, MBBS, Ioannis Mantzaris, MD MS; Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis. Blood. 2019; 134Supplement_1426 doi: https://doi.org/10.1182/blood-2019-123168.
  7. B. Hilda Ye, PhD, Elaine Chung, PhD, Kith Pradhan, PhD, Ana Acuna-Villaorduna, MD, Yanhua Wang, MD PhD, Aditi Shastri, MD, Advaitha Madireddy, PhD, Amit Verma, MBBS, R.Alejandro Sica, MD, Murali Janakiram, MD MS; S-Phase Progression of North American ATLL Cells Is Critically Regulated By the Proto-Oncogene BCL6 and Targetable By PARP Inhibition. Blood. 2019; 134Supplement_13779 doi: https://doi.org/10.1182/blood-2019-131364.
  8. Diego Adrianzen Herrera, MD, Kith Pradhan, PhD, Rosebella Snyder, MD, Siddharth Karanth, MBBS, MPH, DrPH, Murali Janakiram, MD MS, Ioannis Mantzaris, MD MS, Santosh Murthy, MD MPH, Amit Verma, MBBS, Aditi Shastri, MD; Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS). Blood. 2019; 134Supplement_1336 doi: https://doi.org/10.1182/blood-2019-123317
  9. Margarita Kushnir, MD, Radhika Gali, MD, Mariam Alexander, MD, Henny Heisler H. Billett, MD; Efficacy and Safety of Direct Oral Factor Xa Inhibitors in Patients after Bariatric Surgery. Blood. 2019; 134Supplement_12439 doi: https://doi.org/10.1182/blood-2019-127645.
  10. Jesus D Gonzalez-Lugo, MD, Ana Acuna-Villaorduna, MD, Urvi A Shah, MD, Ellen W. Friedman, MD; Effect of Active Hepatitis C Infection in Relapse-Free Survival Among Patients with HIV-Related Diffuse Large B Cell Lymphoma. Blood. 2019; 134Supplement_14132 doi: https://doi.org/10.1182/blood-2019-129379.
  11. Ashley Weiner, Ana Acuna-Villaorduna, Joseph Sparano and Jesus Anampa; Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors. SABCS 2019.
  12. Ana Acuna Villaorduna, Nishi Shah, Sanjay Goel; Clinical features and survival among patients with standard-onset versus early-onset colorectal cancer by age groups. J Clin Oncol 37, 2019 (suppl; abstr 3614).
  13. Nitin Ohri, Haiying Cheng, Shruti Jolly, Shirish M. Gadgeel, Benjamin Thomas Cooper, Elaine Shum, Balazs Halmos; The selective personalized radioimmunotherapy for locally advanced NSCLC trial (SPRINT). J Clin Oncol 37, 2019 (suppl; abstr TPS8571).
  14. Nadia Ashai, Matthew Stuart, Mateo Mejia Saldarriaga, Wei Zhang, Renee Huang, Rahul Narang, Jennifer W. Chuy, Andreas Kaubisch, Sanjay Goel, Balazs Halmos, Lakshmi Rajdev; Cost and effectiveness of genetic testing in metastatic colorectal cancer (mCRC) at Montefiore Medical Center (MMC). J Clin Oncol 37, 2019 (suppl; abstr e15043).
  15. Nadia Ashai, Mateo Mejia Saldarriaga, Devika Rao, Matthew Stuart, Wei Zhang, Sanjay Goel, Balazs Halmos, Lakshmi Rajdev; Molecular analysis of advanced colorectal cancer in a patient cohort of Hispanics, African Americans, and Caucasians within a diverse single institution. J Clin Oncol 37, 2019 (suppl; abstr e15121).
  16. Devika Rao, Ana Acuna Villaorduna, Meghan Kaumaya, Nadia Ashai, Seda Tolu, Adel Chergui, Lakshmi Rajdev, Sanjay Goel; J Clin Oncol 37, 2019 (suppl; abstr e15064).
  17. Nishi Shah, Ana Acuna-Villaorduna, Sanjay Goel; Incidence patterns of early onset colon cancer by race and stage in the US. J Clin Oncol 37, 2019 (suppl; abstr e18168).
  18. Meghan Kaumaya, Wei Zhang, Kevin Kuan, Sorab Gupta, Shaomin Hu, Devika Rao, Kim Ohaegbulam, Richard Hwang, Qiang Liu, Xingxing Zang, Sanjay Goel, Radhashree Maitra; B7-H3 expression by immunohistochemistry as a negative prognostic biomarker in colorectal carcinoma (CRC) in a racially diverse population. J Clin Oncol 37, 2019 (suppl; abstr e15127).
  19. Nishi Shah, Diego Adrianzen Herrera, Urvi Shah, Bhaskar Chandu Kolla, Gurbakhash Kaur, Roberto Alejandro Sica, Aditi Shastri, Ioannis Mantzaris, Amit Verma, Murali Janakiram; Unique racial patterns in rare T-cell lymphomas: A National Cancer Registry analysis from 2001 to 2015. J Clin Oncol 37, 2019 (suppl; abstr e19070).
  20. Ana Acuna Villaorduna, Meghan Kaumaya, Sanjay Goel; Racial disparities in clinico-pathological features and survival rates of early-onset colorectal cancer. J Clin Oncol 37, 2019 (suppl; abstr e15089).
  21. Gurbakhash Kaur, Amanda Podolski, Janki Patel, Jesus Del Santo Anampa Mesias; Body composition change, safety, and efficacy with everolimus use in ethnic minorities with breast cancer. J Clin Oncol 37, 2019 (suppl; abstr e18145).
  22. Diego Andres Adrianzen Herrera, Gaurav Choudhary, Tushar Bhagat, Shanisha Gordon-Mitchell, Hui Zhang, Ulrich Steidl, Britta Will, Gary Eichenbaum, Chandan Guha, Amit Verma; A novel thrombopoietin mimetic RWJ-800088 increases megakaryopoiesis without causing malignant proliferation in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). J Clin Oncol 37, 2019 (suppl; abstr e18527).
  23. Jose Nahun Galeas, Robert M. Grossberg, Maria Serrano, Anna Shmukler, Susan Sakalian, Vikas Mehta, Balazs Halmos, Stuart H. Packer; Improving lung cancer screening in the HIV population. J Clin Oncol 37, 2019 (suppl 27; abstr 69).
  24. Vineeth Sukrithan, Jason Sandler, Rasim A. Gucalp, Richard J. Gralla, Balazs Halmos; Responses to immune checkpoint therapy in pulmonary sarcomatoid carcinoma: A retrospective review. J Clin Oncol 37, 2019 (suppl 8; abstr 115).
  25. Nadia Ashai, Matthew Stuart, Devika Rao, Mateo Mejia Saldarriaga, Wei Zhang, Renee Huang, Rahul Narang, Jennifer W. Chuy, Andreas Kaubisch, Sanjay Goel, Balazs Halmos, Lakshmi Rajdev; Cost and effectiveness of genetic testing in metastatic colorectal cancer (mCRC) at Montefiore Medical Center (MMC). J Clin Oncol 37, 2019 (suppl 4; abstr 643).
  26. Devika Rao, Atrayee Basu Mallick, Amartej Merla, Jeeshan Jiffry, Imran Chaudhary, Titto A Augustine, Lakshmi Rajdev, Andreas Kaubisch, Radhashree Maitra, Sanjay Goel; Excision repair cross-complementing group-1 (ERCC1) gene induction in peripheral blood mononuclear cells as a marker of outcome in patients with colorectal cancer treated with oxaliplatin. J Clin Oncol 37, 2019 (suppl 4; abstr 542).
  27. Ana Acuna Villaorduna, Sanjay Goel; Characteristics and survival among early onset and standard onset colorectal cancer by race. J Clin Oncol 37, 2019 (suppl 4; abstr 522).

2020

  1. Heidi Ko, Yaser Baghdadi, Charito Love, Joseph A. Sparano; Clinical utility of 18F-FDG-PET/CT in staging localized breast cancer prior to initiating preoperative systemic therapy. J Clin Oncol 38: 2020 (suppl; abstr 563).
  2. Michael Wysota, Amanda Jirgal, Ana Acuna-Villaorduna, Shankar Viswanathan, Andreas Kaubisch, Eswar Gadde, Rafi Kabarriti, Sanjay Goel, Jennifer W. Chuy; A phase II trial of preoperative FOLFIRINOX followed by gemcitabine-based chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma (BR PDAC). J Clin Oncol 38: 2020 (suppl; abstr 4638).
  3. Nishi Shah, Riya Jayesh Patel, Astha Thakkar, Shafia Rahman, Ana Acuna-Villaorduna, Urvi Shah, Diego Adrianzen Herrera, Shira Slasky, Kira Gritsman, Mendel Goldfinger, Noah Saul Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier-Rodriguez, Ira Braunschweig, Amit Verma, Katharine Anne McNeill, B. Hilda Ye, Murali Janakiram, R. Alejandro Sica; CNS involvement by North American-ATLL (NA-ATLL) is associated with discrete patterns and molecular profile involving XPO1 E571 and KLF2/PI3KCD in selected cases. J Clin Oncol 38: 2020 (suppl; abstr 8063).
  4. Zunaira H Choudhary, Shailesh M Advani, Nadia Ashai, Sara Tariq, Axel Grothey, Scott Kopetz, Lakshmi Rajdev; A multi-institution analysis of molecular biomarkers in patients with metastatic colorectal cancer in ethnically diverse populations. J Clin Oncol 38: 2020 (suppl; abstr e16074).
  5. Adel Chergui, Eswar Gadde, Ana Acuna-Villaorduna, Rafi Kabarriti, Sanjay Goel, Andreas Kaubisch; Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with immunotherapy: A “real world” retrospective study. J Clin Oncol 38: 2020 (suppl; abstr e16644).
  6. Seda Serra Tolu, Adel Chergui, Devika Rao, Meghan Kaumaya, Ana Acuna-Villaorduna, Andreas Kaubisch, Jennifer W. Chuy, Lakshmi Rajdev, Tarek N. Elrafei, Sanjay Goel; The impact of biologic agents in patients with metastatic colorectal cancer by race/ethnicity. J Clin Oncol 38, 2020 (suppl 4; abstr 156).
  7. Adel Chergui, Eswar Gadde, Seda Serra Tolu, Ana Acuna-Villaorduna, Rafi Kabarriti, Sanjay Goel, Andreas Kaubisch; Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with immunotherapy: A real-world retrospective study. J Clin Oncol 38, 2020 (suppl 4; abstr 557).
  8. Robert Lopez, Anna C. Ferrari, Sanjay Goel, Stephen Peeke, Janaki Neela Sharma, Niraj Konchady Shenoy, Benjamin Adam Gartrell; Genomic profiling of prostate cancer at a diverse academic center. J Clin Oncol 38, 2020 (suppl 6; abstr 64).
  9. Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients. Angelica D'Aiello , Sumaira Zareef, MD , Kith Pradhan, PhD , Amanda Lombardo, PA-C, BS, MS , Fariha Khatun, PA-C , Jennat Mustafa, PA-C , Alyssa De Castro, PharmD , Felisha Joseph, PA-C , Kailyn Gillick, PA-C , Anjali Naik, PA-C , Astha Thakkar, MBBS , Lauren C Shapiro, MD , Shafia Rahman, MD , Zhu Cui, MD , Jesus D Gonzalez Lugo, MD , Fiona Mienko, MBBS , Numa Tarnima Rahman, MD , Robert Lopez, MD , Heidi Chwan Ko, DO , Amanda Podolski, MD , Vikas Mehta, MD , Sanjay Goel, MD , Rafi Kabarriti, MD , Joseph Sparano, MD , Stuart Packer, MD , David Lawrence Fernandes, MD , Enrico Castelucci, MD , Margarita Kushnir, MD , Mark Chaitowitz, MD , Luca Paoluzzi, MD , Ulrich G. Steidl, MDPhD , Phaedon Zavras, MD , Ioannis Mantzaris, MD MS , Noah Kornblum, MD , Aditi Shastri, MD , Lizamarie Bachier-Rodriguez, MD , Kira Gritsman, MDPhD , Henny H. Billett, MD MSc , Rachel Bartash, MD , Yoram Puius, MD PhD , Margaret Mccort, MD , Ira Braunschweig, MD , Mendel Goldfinger, MD , Amit Verma, MBBS , R. Alejandro Sica, MD. Blood (2020) 136 (Supplement 1): 34–35. https://doi.org/10.1182/blood-2020-138842
  10. Dynamics of Leukocyte Subpopulations Reconstitution Predict Infection Propensity in a Multiethnic Real World Cohort Treated with Anti-CD19 CAR-T Cell Therapy (Axicabtagene-Ciloleucel). Astha Thakkar, MBBS , Zhu Cui, MD , Stephen Zachary Peeke, MD , Nishi Shah, MBBS, MPH , Amanda Lombardo, PA-C, BS, MS , Fariha Khatun, PA-C , Jennat Mustafa, PA-C , Alyssa De Castro, PharmD , Kailyn Gillick, PA-C , Felisha Joseph, PA-C , Anjali Naik, PA-C , Shafia Rahman, MD , Angelica D'Aiello , Richard Elkind, PA-C, MS , Susan Sakalian , Karen Fehn, RN, BSN , Karen Wright, RN-BC, MS, OCN, BMTCN , Michelly Abreu, ANP,MSN , Latoya Townsend Nugent, NP , Nicole Chambers, ANP/FNP , Rosmi Mathew, FNP-BC , Donika Binakaj, BBA , Randin Nelson, MD , Carlo Palesi , Monika Paroder, MD , Joan Uehlinger, MD , Yanhua Wang, MD PhD , Yang Shi, MD PhD , Xingxing Zang, PhD , Hao Wang, MS , Christopher Nishimura, BS , Xiaoxin Ren , Ulrich G. Steidl, MDPhD , Kira Gritsman, MDPhD , Murali Janakiram , Noah Kornblum, MD , Olga Derman, MD , Ioannis Mantzaris, MD MS , Aditi Shastri, MD , Rachel Bartash, MD , Yoram Puius, MD PhD , Margaret McCort, MD , Mendel Goldfinger, MD , Lizamarie Bachier-Rodriguez, MD , Amit Verma, MBBS , Ira Braunschweig, MD , R. Alejandro Sica, MD. Blood (2020) 136 (Supplement 1): 10–11. https://doi.org/10.1182/blood-2020-139533
  11. Prognostic Factors for North American Adult T Cell Leukemia Lymphoma: Defining Risk Groups Using a Four-Point Score Prognostic System. Shafia Rahman, MD , Alvaro Alvarez Soto, MD , Lindor Qunaj, MD , Kenny Ye , Kith Pradhan, PhD , Astha Thakkar, MBBS , Zhu Cui, MD , Michal Kasher Meron , Angelica D'Aiello , Amanda Lombardo, PA-C, BS, MS , Jennat Mustafa, PA-C , Fariha Khatun, PA-C , Kailyn Gillick, PA-C , Felisha Joseph, PA-C , Anjali Naik, PA-C , Alyssa De Castro, PharmD , Ulrich G. Steidl, MDPhD , Hao Wang, MS , Xiaoxin Ren , Xingxing Zang, PhD , Olga Derman, MD , Kira Gritsman, MDPhD , Noah Kornblum, MD , Aditi Shastri, MD , Ioannis Mantzaris, MD MS , Mendel Goldfinger, MD , Ira Braunschweig, MD , B. Hilda Ye, PhD , Amit Verma, MBBS , Murali Janakiram, MD , Urvi A Shah, MD , R. Alejandro Sica, MD. Blood (2020) 136 (Supplement 1): 38–39. https://doi.org/10.1182/blood-2020-141428.
  12. Allogeneic Stem Cell Transplantation in a Large Urban Cohort of North-American Adult T-Cell Leukemia/Lymphoma. Astha Thakkar, MBBS , Diego Adrianzen Herrera, MD , Shafia Rahman, MD , Zhu Cui, MD , Angelica D'Aiello , Amanda Lombardo, PA-C, BS, MS , Fariha Khatun, PA-C , Jennat Mustafa, PA-C , Kailyn Gillick, PA-C , Felisha Joseph, PA-C , Anjali Naik, PA-C , Latoya Townsend Nugent, NP , Nicole Chambers, ANP/FNP , Rosmi Mathew, FNP-BC , Michelly Abreu, ANP,MSN , Richard Elkind, PA-C, MS , Henrietta Noicely, RN, MSN, FNP, CNL , Ruby Yusay, BSN, RN , Carlo Palesi , Randin Nelson, MD , Donika Binakaj, BBA , Ulrich G. Steidl, MDPhD , Olga Derman, MD , Kira Gritsman, MDPhD , Noah Kornblum, MD , Ioannis Mantzaris, MD MS , Aditi Shastri, MD , Mendel Goldfinger, MD , Lizamarie Bachier-Rodriguez, MD , B. Hilda Ye, PhD , Amit Verma, MBBS , Ira Braunschweig, MD , Murali Janakiram , R. Alejandro Sica, MD. Blood (2020) 136 (Supplement 1): 21–22. https://doi.org/10.1182/blood-2020-140812.
  13. Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma. Yasunori Kogure, MD PhD , Takuro Kameda, MD PhD , Junji Koya, PhD MD , Ayako Kamiunten, MD , Kotaro Shide, MD PhD , Tomonori Hidaka, MD , Yoko Kubuki, MD PhD , Makoto Yoshimitsu, MD PhD , Kisato Nosaka, MD PhD , Yoshitaka Imaizumi, MD PhD , Mizuki Watanabe, MD , Yuki Saito, MD , Marni B McClure, MD PhD , Mariko Tabata, MD , Sumito Shingaki, PhD MD , Kota Yoshifuji, MD , Yuichi Shiraishi, PhD , Michihiro Hidaka, MD PhD , Atae Utsunomiya, MD , Urvi A. Shah, MD , Ana Acuna-Villaorduna, MD , Aditi Shastri, MD , R. Alejandro Sica, MD , Murali Janakiram, MD , Juan Carlos Ramos, MD BS , Tatsuhiro Shibata, MD PhD , Akifumi Takaori-Kondo, MD PhD , Yasushi Miyazaki, MD PhD , Masao Matsuoka, MDPhD , Kenji Ishitsuka, MD PhD , Seishi Ogawa, MD PhD , B. Hilda Ye, PhD , Kazuya Shimoda, MD PhD , Keisuke Kataoka, MD PhD. Blood (2020) 136 (Supplement 1): 29–30. https://doi.org/10.1182/blood-2020-134360.
  14. Retrospective Comparison of Doac with Enoxaparin in Gastrointestinal and Urothelial Cancers. Shafia Rahman, MD, Juan Trias, MD, Mohammad Barouqa, MD, Margarita Kushnir, MD, Henny H. Billett, MD MSc. Blood (2020) 136 (Supplement 1): 21. https://doi.org/10.1182/blood-2020-143409.
  15. Late-Onset Cytokine Release Syndrome (CRS) in HIV Patient with Relapsed Classical Hodgkin Lymphoma on Nivolumab and Non-Compliance with Anti-Retroviral Therapy. Radhika Gali, MD , David Alejos , Ioannis Mantzaris, MD MS. Blood (2020) 136 (Supplement 1): 17. https://doi.org/10.1182/blood-2020-142025.
  16. Immunophenotypes and Clinical Outcomes in Adult Patients with Sickle Cell Disease: Lymphopenia Correlates with End Organ Damage. Stephen Zachary Peeke, MD , Qi Gao, PhD , Jaeun Choi, PhD , Khadijah Abdallah, MPH , Ashley Buscetta, MSN, FNP-BC, CWOCN , Andrew Crouch , Shuo You, MD PhD , Vence L. Bonham, JD , Caterina P Minniti, MD. Blood (2020) 136 (Supplement 1): 12–13. https://doi.org/10.1182/blood-2020-142634.
  17. Improving vaccine administration in patients with solid malignancies in the outpatient setting. Mariam Alexander, Matthew Stuart, Jose Nahun Galeas, Roy Browne, Jim McCarthy, Stuart H. Packer. J Clin Oncol 38, 2020 (suppl 29; abstr 194). DOI:10.1200/JCO.2020.38.29_suppl.194

2021

  1. Effect of Medicaid expansion on incidence of early-onset colorectal cancer incidence among Hispanics. Shafia Rahman, Riya Jayesh Patel, Jianyou Liu, Ana Acuna-Villaorduna, Mimi Kim, Sanjay Goel. J Clin Oncol 39, 2021 (suppl 15; abstr 3547).
  2. Effect of cyclin-dependent kinase 4 and 6 inhibitors (CDKIs) on body composition (BC) in patients (pts) with hormone receptor-positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC). Lisa Phuong, Janki Patel, Nadia Baka, Jessica Goldman, Michael Lyudmer, Stephanie Shamir, Junwen Deng, Alvaro Alvarez Soto, Jesus Del Santo Anampa Mesias. J Clin Oncol 39, 2021 (suppl 15; abstr e13033).
  3. Factors associated with long-term survival in patients with early-onset and standard-onset colorectal cancer. Riya Jayesh Patel, Michael Lyudmer, Adel Chergui, Seda Serra Tolu, Devika Rao, Andreas Kaubisch, Jennifer W. Chuy, Tarek N. Elrafei, Ana Acuna-Villaorduna, Sanjay Goel. J Clin Oncol 39, 2021 (suppl 3; abstr 141).
  4. Racial ethnic disparities in Clinical/pathological features, treatment, and survival among patients with early-onset colorectal cancer. Michael Lyudmer, Riya Jayesh Patel, Adel Chergui, Seda Serra Tolu, Devika Rao, Andreas Kaubisch, Jennifer W. Chuy, Tarek N. Elrafei, Ana Acuna-Villaorduna, Sanjay Goel. J Clin Oncol 39, 2021 (suppl 3; abstr 21).
  5. The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer. Vaibhav G. Patel, Xiaobo Zhong, Neil J. Shah, Luis Pina Martina, Jessica Hawley, Emily Lin, Benjamin Adam Gartrell, Victor Ricardo Adorno Febles, David R Wise, Qian Qin, George Mellgard, Jones T. Nauseef, David Green, Panagiotis J. Vlachostergios, Daniel Kwon, Franklin W. Huang, Bobby Chi-Hung Liaw, Scott T. Tagawa, Michael J. Morris, William K. Oh. J Clin Oncol 39, 2021 (suppl 6; abstr 41). DOI:10.1200/JCO.2021.39.6_suppl.41.
  6. Assessing Clinical Outcomes in Patients Undergoing Splenectomy for Immune Thrombocytopenia: A Real World Perspective. Emma Rabinovich, Kith Pradhan, Helen Tracy Davido, Radhika Gali, Iffath Islam, Peter Muscarella, Henny H. Billett, Blood (2021) 138 (Supplement 1):3161. DOI: https://doi.org/10.1182/blood-2021-151764.
  7. Safety of Autologous Hematopoietic Stem Cell Transplantation in Patients over 75 Years Old. Single Center Experience Serving a Minority Population. Kateryna Fedorov, Tanim Jain, Jennat Mustafa, Amanda Lombardo, Fariha Khatun, Felisha Joseph, Kailyn Gillick, Anjali Naik, Richard Elkind, Michelly Abreu, Karen Fehn, Alyssa De Castro, Kith Pradhan, Donika Binakaj, Randin Nelson, Monika Paroder, Joan Uehlinger, Carlo Palesi, Kira Gritsman, R. Alejandro Sica, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier-Rodriguez, Amit Verma, Ira Braunschweig, Mendel Goldfinger. Blood (2021) 138 (Supplement 1): 1833. DOI: https://doi.org/10.1182/blood-2021-146532
  8. Seroconversion Rates after COVID-19 Vaccination Amongst Patients with Hematologic Malignancies: Results of a Rapid Vaccination and Evaluation Program in a Minority Rich, Ethnically Diverse Inner City Cohort. Lauren C Shapiro, Radhika Gali, Astha Thakkar, Jesus D Gonzalez-Lugo, Abdul Hamid Bazarbachi, Shafia Rahman, Kith Pradhan, Karen Fehn, Michelly Abreu, Noah Kornblum, Kira Gritsman, Mendel Goldfinger, Aditi Shastri, Ioannis Mantzaris, Ira Braunschweig, Balazs Halmos, Amit Verma, Margaret McCort, Lizamarie Bachier-Rodriguez, R. Alejandro Sica. Blood (2021) 138 (Supplement 1): 2537. DOI: https://doi.org/10.1182/blood-2021-151309.
  9. Cardiovascular Side Effects of Chimeric Antigen Receptor (CAR) T-Cell Products: A Single Center Experience in a Minority Rich, Ethnically Diverse Real-World Cohort. Sumaira Zareef, Astha Thakkar, Ryann Quinn, An Tran, Alyssa De Castro, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend Nugent, Richard Elkind, Kira Gritsman, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Lili Zhang, Amit Verma, Ira Braunschweig, R. Alejandro Sica. Blood (2021) 138 (Supplement 1): 3840. DOI: https://doi.org/10.1182/blood-2021-154004.
  10. Predictors of Central Nervous System (CNS) Involvement in North American Adult T-Cell Leukemia Lymphoma (ATLL) and Their Survival Pattern. Riya Patel, Shafia Rahman, Nishi Shah, Astha Thakkar, Ana Acuna-Villaorduna, Urvi A Shah, Diego Adrianzen Herrera, Alyssa De Castro, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend Nugent, Yanhua Wang, Olga Derman, Shira Slasky, Kira Gritsman, Ulrich G. Steidl, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier-Rodriguez, Ira Braunschweig, Amit Verma, Katharine McNeill, B. Hilda Ye, Murali Janakiram, R. Alejandro Sica. Blood (2021) 138 (Supplement 1): 1400. DOI: https://doi.org/10.1182/blood-2021-151447.
  11. Neurotoxicity of Axicabtagene Ciloleucel and Long-Term Outcomes - in a Minority Rich, Ethnically Diverse Real World Cohort. Ryann Quinn, Astha Thakkar, Sumaira Zareef, Richard Elkind, Karen Wright, Karen Fehn, Susan Sakalian, Michelly Abreu, Alyssa De Castro, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend Nugent, Kira Gritsman, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Lili Zhang, Katharine McNeill, Elizabeth Michell, Mark Milstein, Amit Verma, Ira Braunschweig, R. Alejandro Sica. Blood (2021) 138 (Supplement 1): 4842. DOI: https://doi.org/10.1182/blood-2021-153917.
  12. Safety of Direct Acting Oral Anticoagulants (DOACs) in Comparison to Low Molecular Weight Heparin (LWMH) in Gastrointestinal and Genito-Urinary Cancers. Shafia Rahman, Juan Trias, Margarita Kushnir, Henny H. Billett. Blood (2021) 138 (Supplement 1): 1070. DOI: https://doi.org/10.1182/blood-2021-153442.
  13. Lenalidomide and Eltrombopag for Treatment in Low or Intermediate Risk Myelodysplastic Syndrome: Result of a Phase 2 Study Combination Clinical Trial. Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William Donnellan, Prafulla Bhagat, Karen Fehn, Cassady Remy, Sakshi Jasra, Mohammad Kazemi, Ioannis Mantzaris, R. Alejandro Sica, Lizamarie Bachier-Rodriguez, Mendel Goldfinger, Noah Kornblum, Kira Gritsman, Ira Braunschweig, Ulrich G. Steidl, Britta Will, Aditi Shastri, Amit Verma. Blood (2021) 138 (Supplement 1): 65. DOI: https://doi.org/10.1182/blood-2021-146597.
  14. Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies. Lauren C Shapiro, Ioannis Mantzaris, Aditi Shastri, R. Alejandro Sica, Lizamarie Bachier-Rodriguez, Noah Kornblum, Kira Gritsman, Eric J. Feldman, Amit Verma, Ira Braunschweig, Yogenthiran Saunthararajah, Mendel Goldfinger. Blood (2021) 138 (Supplement 1): 4428. DOI: https://doi.org/10.1182/blood-2021-145.
  15. A Transgenic Murine Model Expressing Hyperactive STAT3 Recapitulates the Features of MDS/AML Bianca L Rivera, Shanisha Gordon, Srinivas Aluri, Yang Shi, Samarpana Chakraborty, Gaurav S Choudhary, Lauren C Shapiro, Kith Pradhan, David A. Frank, Sergei B. Koralov, Amit Verma, Aditi Shastri. Blood (2021) 138 (Supplement 1): 3308. DOI: https://doi.org/10.1182/blood-2021-151691.

Articles

2019

  1. Adrianzen Herrera D, Kornblum N, Derman O, Bachier-Rodriguez L, Sica RA, Shastri A, Janakiram M, Verma A, Braunschweig I, Mantzaris I.Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts. Clin Lymphoma Myeloma Leuk. 2019;19(8):516-521. doi:10.1016/j.clml.2019.05.002.
  2. Acuna-Villaorduna A, Tran V, Gonzalez-Lugo JD, Azimi-Nekoo E, Billett HH. Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort study. Thromb Res. 2019;174:137-140. doi:10.1016/j.thromres.2018.12.019.
  3. Sridharan A, Schinke CD, Georgiev G, Da Silva Ferreira M, Thiruthuvanathan V, MacArthur I, Bhagat TD, Choudhary GS, Aluri S, Chen J, Pradhan K, Xia Y, Panjikaran M, Sims G, Bhagat CK, Bender R, Keeler L, Graber A, Heuck C, Fletcher FA, Alapat D, Weinhold N, Johnson SK, Wickrema A, Barlogie B, Morgan GJ, Shastri A, Steidl U, Will B, Verma A. Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias. Blood Adv. 2019;3(23):3962-3967. doi:10.1182/bloodadvances.2019000731.
  4. Hemmati S, Sinclair T, Tong M, Bartholdy B, Okabe RO, Ames K, Ostrodka L, Haque T, Kaur I, Mills TS, Agarwal A, Pietras EM, Zhao JJ, Roberts TM, Gritsman K. PI3 kinase alpha and delta promote hematopoietic stem cell activation. JCI Insight. 2019;5(13):e125832. Published 2019 May 23. doi:10.1172/jci.insight.1258.
  5. Adrianzen Herrera D, Kornblum N, Acuna-Villaorduna A, Sica RA, Shah U, Butler M, Vishnuvardhan N, Shah N, Bachier-Rodriguez L, Derman O, Shastri A, Mantzaris I, Verma AK, Braunschweig I, Janakiram M. Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell transplant - a case series. Leuk Lymphoma. 2019;60(2):395-401. doi:10.1080/10428194.2018.1474523.
  6. Sukrithan V, Sandler J, Gucalp R, Gralla R, Halmos B. Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma. Clin Lung Cancer. 2019;20(3):e242-e246. doi:10.1016/j.cllc.2018.12.013.
  7. Adrianzen Herrera D, Ashai N, Perez-Soler R, Cheng H.Nanoparticle Albumin Bound-Paclitaxel for Treatment of Advanced Non-Small Cell Lung Cancer: An Evaluation of the Clinical Evidence. Expert Opin Pharmacother. 2019 Jan;20(1):95-102. doi: 10.1080/14656566.2018.1546290. Epub 2018 Nov 15. PMID: 30439289.
  8. Augustine T, Maitra R, Zhang J, Nayak J, Goel S; Sensitization of Colorectal Cancer to Irinotecan Therapy by PARP Inhibitor Rucaparib. Invest New Drugs. 2019 Oct;37(5):948-960. doi: 10.1007/s10637-018-00717-9. Epub 2019 Jan 5. PMID: 30612311.
  9. Peeke SZ, Gritsman K. Twist of Fate for Acute Promyelocytic Leukemia: TRIB3-TWIST1 Interaction Promotes Resistance. Clin Cancer Res. 2019 Oct 15; 25(20):6018-6020. doi: 10.1158/1078-0432.CCR-19-2140. Epub 2019 Aug 12. PMID: 31405833.
  10. Galeas JN, Gaspe N, Pradhan K, Cordero H, Verma A, Goel S. Anisocytosis Is a Poor Prognostic Factor in Secondary Polycythemia. Leuk Lymphoma. 2019 Dec; 60(13):3287-3291. doi: 10.1080/10428194.2019.1622701. Epub 2019 Jun 13. PMID: 31190587.
  11. Wang H, Kaur G, Sankin AI, Chen F, Guan F, Zang X.Immune Checkpoint Blockade and CAR-T Cell Therapy in Hematologic Malignancies. J Hematol Oncol. 2019 Jun 11;12(1):59. doi: 10.1186/s13045-019-0746-1. PMID: 31186046.
  12. Acuna-Villaorduna A, Gonzalez-Lugo J, Ye BH, Adrianzen Herrera DA, Sica RA, Shah U, Shah N, Kornblum N, Braunschweig I, Derman O, Mantzaris I, Shastri A, Wang Y, Verma A, Zalta B, Janakiram M. High Prevalence of Pulmonary Findings in Computed Tomographies of HTLV-1-infected Patients With and Without adult-T Cell leukemia/lymphoma - Implications for Staging. Leuk Lymphoma. 2019 Dec;60(13):3272-3276. doi: 10.1080/10428194.2019.1627543. Epub 2019 Jun 17. PMID: 31204876.
  13. Kam AE, Pendurti G, Shah UH, Ghalib MH, Chaudhary I, Chuy J, Rajdev L, Kaubisch A, Aparo S, Mantzaris I, Goel S; Survival Outcome and Prognostic Model of Patients With Colorectal Cancer on Phase 1 Trials. Invest New Drugs. 2019 Jun;37(3):490-497. doi: 10.1007/s10637-018-0675-9. Epub 2018 Oct 12. PMID: 30315379.
  14. Sukrithan V, Deng L, Barbaro A, Cheng H; Emerging Drugs for EGFR-mutated Non-Small Cell Lung Cancer. Expert Opin Emerg Drugs. 2019 Mar;24(1):5-16. doi: 10.1080/14728214.2018.1558203. Epub 2018 Dec 20. PMID: 30570396.
  15. Kushnir M, Choi Y, Eisenberg R, Rao D, Tolu S, Gao J, Mowrey W, Billett HH. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Lancet Haematol. 2019 Jul;6(7):e359-e365. doi: 10.1016/S2352-3026(19)30086-9. Epub 2019 May 24. PMID: 31133411.
  16. Rao D, Mallick AB, Augustine T, Daroqui C, Jiffry J, Merla A, Chaudhary I, Seetharam R, Sood A, Gajavelli S, Aparo S, Rajdev L, Kaubisch A, Chuy J, Negassa A, Mariadason JM, Maitra R, Goel S. Excision Repair Cross-Complementing group-1 (ERCC1) Induction Kinetics and Polymorphism Are Markers of Inferior Outcome in Patients With Colorectal Cancer Treated With Oxaliplatin. Oncotarget. 2019 Sep 17;10(53):5510-5522. doi: 10.18632/oncotarget.27140. eCollection 2019 Sep 17. PMID: 31565185.
  17. Galeas JN, Gaspe N, Pradhan K, Cordero H, Verma A, Goel S. Anisocytosis is a poor prognostic factor in secondary polycythemia. Leuk Lymphoma. 2019;60(13):3287-3291. doi:10.1080/10428194.2019.1622701.
  18. Adrianzen Herrera D, Ashai N, Perez-Soler R, Cheng H. Nanoparticle Albumin Bound-Paclitaxel for Treatment of Advanced Non-Small Cell Lung Cancer: An Evaluation of the Clinical Evidence. Expert Opin Pharmacother. 2019 Jan;20(1):95-102. doi: 10.1080/14656566.2018.1546290. Epub 2018 Nov 15. PMID: 30439289.
  19. Kushnir M, Choi Y, Eisenberg R, Rao D, Tolu S, Gao J, Mowrey W, Billett HH. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. Lancet Haematol. 2019;6(7):e359-e365. doi:10.1016/S2352-3026(19)30086-9
  20. Augustine T, Maitra R, Zhang J, Nayak J, Goel S; Sensitization of Colorectal Cancer to Irinotecan Therapy by PARP Inhibitor Rucaparib. Invest New Drugs. 2019 Oct;37(5):948-960. doi: 10.1007/s10637-018-00717-9. Epub 2019 Jan 5. PMID: 30612311.

2020

  1. Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A. Myelodysplastic Syndromes and the Risk of Cardiovascular Disease in Older Adults: A SEER-medicare Analysis. Leukemia. 2020 Jun;34(6):1689-1693. doi: 10.1038/s41375-019-0673-8. Epub 2019 Dec 16. PMID: 31844145.
  2. Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A. Myelodysplastic Syndromes and the Risk of Cardiovascular Disease in Older Adults: A SEER-medicare Analysis. Leukemia. 2020 Jun;34(6):1689-1693. doi: 10.1038/s41375-019-0673-8. Epub 2019 Dec 16. PMID: 31844145.
  3. Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, Pradhan K, Thota R, Reissman S, Sparano JA, Gartrell BA, Smith RV, Ohri N, Garg M, Racine AD, Kalnicki S, Perez-Soler R, Halmos B, Verma A. Case Fatality Rate of Cancer Patients With COVID-19 in a New York Hospital System. Cancer Discov. 2020 May 1. doi: 10.1158/2159-8290.CD-20-0516.
  4. Verma A, Suragani RN, Aluri S, Shah N, Bhagat TD, Alexander MJ, Komrokji R, Kumar R. Biological Basis for Efficacy of Activin Receptor Ligand Traps in Myelodysplastic Syndromes. J Clin Invest. 2020 Feb 3;130(2):582-589. doi: 10.1172/JCI133678. PMID: 31961337.
  5. Deng Q, Fang Q, Sun H, Singh AP, Alexander M, Li S, Cheng H, Zhou S. Detection of Plasma EGFR Mutations for Personalized Treatment of Lung Cancer Patients Without Pathologic Diagnosis. Cancer Med. 2020 Mar;9(6):2085-2095. doi: 10.1002/cam4.2869. Epub 2020 Jan 28. PMID: 31991049.
  6. Sukrithan V, Barbaro A, Chergui A, Ko B, Lin J, Cheng H, Goel S. Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung Cancer. Am J Clin Oncol. 2020 Jan;43(1):64-68. doi: 10.1097/COC.0000000000000628. PMID: 31764022.
  7. Alexander M, Ko B, Lambert R, Gadgeel S, Halmos B. The Evolving Use of Pembrolizumab in Combination Treatment Approaches for Non-Small Cell Lung Cancer. Expert Rev Respir Med. 2020 Feb;14(2):137-147. doi: 10.1080/17476348.2020.1702526. Epub 2019 Dec 17. PMID: 31815565.
  8. Singh AP, Shum E, Rajdev L, Cheng H, Goel S, Perez-Soler R, Halmos B. Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice. Cancers (Basel). 2020 May 4;12(5):1156. doi: 10.3390/cancers12051156. PMID: 32375398.
  9. Sukrithan V, Barbaro A, Chergui A, Ko B, Lin J, Cheng H, Goel S. Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Non squamous Non-Small Cell Lung Cancer. Am J Clin Oncol. 2020;43(1):64-68. doi:10.1097/COC.0000000000000628.
  10. Gonzalez-Lugo JD, Bachier-Rodriguez L, Goldfinger M, Shastri A, Sica RA, Gritsman K, Mehta V, Kabarriti R, Goel S, Verma A, Braunschweig I, Kornblum N, Mantzaris I. A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19 [published online ahead of print, 2020 Jun 1]. Br J Haematol. 2020;10.1111/bjh.16906. doi:10.1111/bjh.16906.
  11. Abbasi A, Peeke S, Shah N, Mustafa J, Khatun F, Lombardo A, Abreu M, Elkind R, Fehn K, de Castro A, Wang Y, Derman O, Nelson R, Uehlinger J, Gritsman K, Sica RA, Kornblum N, Mantzaris I, Shastri A, Janakiram M, Goldfinger M, Verma A, Braunschweig I, Bachier-Rodriguez L. Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis. J Hematol Oncol. 2020;13(1):1. Published 2020 Jan 3. doi:10.1186/s13045-019-0838-y.
  12. Xiao Z, Acuna-Villaorduna A, Mantzaris I. Brachial plexopathy following autologous hematopoietic stem cell transplant: an unrecognized complication of autologous transplantation. Leuk Lymphoma. 2020;61(1):243-245. doi:10.1080/10428194.2019.1654094.
  13. Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A. Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis. Leukemia. 2020;34(6):1689-1693. doi:10.1038/s41375-019-0673-8.
  14. Deng Q, Fang Q, Sun H, Singh AP, Alexander M, Li S, Cheng H, Zhou S. Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis. Cancer Med. 2020;9(6):2085-2095. doi:10.1002/cam4.2869.
  15. Billett HH, Reyes-Gil M, Szymanski J, Ikemura K, Stahl LR, Lo Y, Rahman S, Gonzalez-Lugo JD, Kushnir M, Barouqa M, Golestaneh L, Bellin E. Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality. Thromb Haemost. 2020 Dec;120(12):1691-1699. doi: 10.1055/s-0040-1720978. Epub 2020 Nov 13. PMID: 33186991; PMCID: PMC7869055.
  16. Alexander M, Kim SY, Cheng H. Update 2020: Management of Non-Small Cell Lung Cancer. Lung. 2020 Dec;198(6):897-907. doi: 10.1007/s00408-020-00407-5. Epub 2020 Nov 11. PMID: 33175991; PMCID: PMC7656891.
  17. Gonzalez-Lugo JD, Bachier-Rodriguez L, Goldfinger M, Shastri A, Sica RA, Gritsman K, Mehta V, Kabarriti R, Goel S, Verma A, Braunschweig I, Kornblum N, Mantzaris I. A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19. Br J Haematol. 2020 Aug;190(3):e130-e133. doi: 10.1111/bjh.16906. Epub 2020 Jun 24. PMID: 32479664; PMCID: PMC7300638.
  18. Reyes Gil M, Barouqa M, Szymanski J, Gonzalez-Lugo JD, Rahman S, Billett HH. Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19). JAMA Net w Open. 2020 Aug 3;3(8):e2017539. doi: 10.1001/jamanetworkopen.2020.17539. PMID: 32785632.
  19. Alexander M, Lin E, Cheng H. Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations. Curr Treat Options Oncol. 2020 Jul 28;21(9):72. doi: 10.1007/s11864-020-00759-3. PMID: 32725549.
  20. Phuong L, Rajdev L. Immunotherapy in Anal Cancer. Curr Oncol Rep. 2020 Jul 11;22(9):94. doi: 10.1007/s11912-020-00946-3. PMID: 32651760.
  21. Kim SY, Halmos B. Choosing the best first-line therapy: NSCLC with no actionable oncogenic driver. Lung Cancer Manag. 2020 Jul 24;9(3):LMT36. doi: 10.2217/lmt-2020-0003. PMID: 32774467; PMCID: PMC7399613.
  22. Mienko F, Halmos B, Cheng H. Is pembrolizumab monotherapy the optimal treatment for elderly patients with PD-L1 positive advanced non-small cell lung cancer? Ann Transl Med. 2020 Jun;8(12):778. doi: 10.21037/atm.2020.02.68. PMID: 32647703; PMCID: PMC7333146.
  23. Shah N, Rockwell B, Kazemi M, Peeke S, Bachier-Rodriguez L, Sica RA, Goldfinger M, Kornblum N, Braunschweig I, Shastri A, Verma A, Mantzaris I. Ethnic disparities in survival of adult B-cell acute lymphoblastic leukemia in modern era - a SEER analysis. Leuk Lymphoma. 2020 Dec;61(14):3503-3506. doi: 10.1080/10428194.2020.1808211. Epub 2020 Sep 22. PMID: 32960113.
  24. Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, Pradhan K, Thota R, Reissman S, Sparano JA, Gartrell BA, Smith RV, Ohri N, Garg M, Racine AD, Kalnicki S, Perez-Soler R, Halmos B, Verma A. Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020 Jul;10(7):935-941. doi: 10.1158/2159-8290.CD-20-0516. Epub 2020 May 1. PMID: 32357994; PMCID: PMC7334098.
  25. Ko H, Baghdadi Y, Love C, Sparano JA. Clinical Utility of 18F-FDG PET/CT in Staging Localized Breast Cancer Before Initiating Preoperative Systemic Therapy. J Natl Compr Canc Netw. 2020 Sep;18(9):1240-1246. doi: 10.6004/jnccn.2020.7592. PMID: 32886897.
  26. Shusterman M, Jou E, Kaubisch A, Chuy JW, Rajdev L, Aparo S, Tang J, Ohri N, Negassa A, Goel S. The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer. J Gastrointest Cancer. 2020 Sep;51(3):868-876. doi: 10.1007/s12029-019-00316-8. PMID: 31677056.
  27. Wang X, Lopez R, Luchtel RA, Hafizi S, Gartrell B, Shenoy N. Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. Kidney Int. 2021 Jan;99(1):75-85. doi: 10.1016/j.kint.2020.08.028. Epub 2020 Sep 17. PMID: 32949550.

2021

  1. Kaur G, Mejia Saldarriaga M, Shah N, Catamero DD, Yue L, Ashai N, Goradia N, Heisler J, Xiao Z, Ghalib N, Aaron T, Cole D, Foreman R, Mantzaris I, Derman O, Bachier L, Sica RA, Kornblum N, Braunschweig I, Shastri A, Goel S, Verma A, Janakiram M. Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data. Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4): e384-e397. doi: 10.1016/j.clml.2020.11.013. Epub 2020 Nov 21. PMID: 33339770.
  2. Wang X, Lopez R, Luchtel RA, Hafizi S, Gartrell B, Shenoy N. Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. Kidney Int. 2021 Jan;99(1):75-85. doi: 10.1016/j.kint.2020.08.028. Epub 2020 Sep 17. PMID: 32949550.
  3. Oh SY, Rahman S, Sparano JA. Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancer. Expert Opin Pharmacother. 2021 Jun 7:1-23. doi: 10.1080/14656566.2021.1876662. Epub ahead of print. PMID: 33646064.
  4. Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, Peters S, Rini BI, Thompson MA, Mishra S, Rivera DR, Acoba JD, Abidi MZ, Bakouny Z, Bashir B, Bekaii-Saab T, Berg S, Bernicker EH, Bilen MA, Bindal P, Bishnoi R, Bouganim N, Bowles DW, Cabal A, Caimi PF, Chism DD, Crowell J, Curran C, Desai A, Dixon B, Doroshow DB, Durbin EB, Elkrief A, Farmakiotis D, Fazio A, Fecher LA, Flora DB, Friese CR, Fu J, Gadgeel SM, Galsky MD, Gill DM, Glover MJ, Goyal S, Grover P, Gulati S, Gupta S, Halabi S, Halfdanarson TR, Halmos B, Hausrath DJ, Hawley JE, Hsu E, Huynh-Le M, Hwang C, Jani C, Jayaraj A, Johnson DB, Kasi A, Khan H, Koshkin VS, Kuderer NM, Kwon DH, Lammers PE, Li A, Loaiza-Bonilla A, Low CA, Lustberg MB, Lyman GH, McKay RR, McNair C, Menon H, Mesa RA, Mico V, Mundt D, Nagaraj G, Nakasone ES, Nakayama J, Nizam A, Nock NL, Park C, Patel JM, Patel KG, Peddi P, Pennell NA, Piper-Vallillo AJ, Puc M, Ravindranathan D, Reeves ME, Reuben DY, Rosenstein L, Rosovsky RP, Rubinstein SM, Salazar M, Schmidt AL, Schwartz GK, Shah MR, Shah SA, Shah C, Shaya JA, Singh SRK, Smits M, Stockerl-Goldstein KE, Stover DG, Streckfuss M, Subbiah S, Tachiki L, Tadesse E, Thakkar A, Tucker MD, Verma AK, Vinh DC, Weiss M, Wu JT, Wulff-Burchfield E, Xie Z, Yu PP, Zhang T, Zhou AY, Zhu H, Zubiri L, Shah DP, Warner JL, Lopes G. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol. 2021 Jun;32(6):787-800. doi: 10.1016/j.annonc.2021.02.024. Epub 2021 Mar 19. PMID: 33746047; PMCID: PMC7972830.
  5. Astha Thakkar, Kith Pradhan, Shawn Jindal, Zhu Cui, Bradley Rockwell, Akash Shah, Stuart Packer, R Alejandro Sica, Joseph Sparano, D Yitzhak Goldstein, Amit Verma, Sanjay Goel, Balazs Halmos. Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy. Nat Cancer 2, 392–399 (2021). https://doi.org/10.1038/s43018-021-00191-y.
  6. Thakkar A, Gonzalez-Lugo JD, Goradia N, Gali R, Shapiro LC, Pradhan K, Rahman S, Kim SY, Ko B, Sica RA, Kornblum N, Bachier-Rodriguez L, McCort M, Goel S, Perez-Soler R, Packer S, Sparano J, Gartrell B, Makower D, Goldstein YD, Wolgast L, Verma A, Halmos B. Seroconversion rates following COVID-19 vaccination among patients with cancer. Cancer Cell. 2021 Aug 9;39(8):1081-1090.e2. doi: 10.1016/j.ccell.2021.06.002. Epub 2021 Jun 5. PMID: 34133951; PMCID: PMC8179248.
  7. Tariq S, Kim SY, Monteiro de Oliveira Novaes J, Cheng H. Update 2021: Management of Small Cell Lung Cancer. Lung. 2021 Dec;199(6):579-587. doi: 10.1007/s00408-021-00486-y. Epub 2021 Nov 10. PMID: 34757446.
  8. Wong KJ, Shusterman M, Goel S, Negassa A, Lin J, Gartrell BA. Racial Diversity Among Histology of Renal Cell Carcinoma at an Urban Medical Center. Clin Genitourin Cancer. 2021 Jun;19(3):e166-e170. doi: 10.1016/j.clgc.2020.12.010. Epub 2021 Jan 6. PMID: 33602582.
  9. Shapiro LC, Thakkar A, Campbell ST, Forest SK, Pradhan K, Gonzalez-Lugo JD, Quinn R, Bhagat TD, Choudhary GS, McCort M, Sica RA, Goldfinger M, Goel S, Anampa JD, Levitz D, Fromowitz A, Shah AP, Sklow C, Alfieri G, Racine A, Wolgast L, Greenberger L, Verma A, Halmos B. Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer. Cancer Cell. 2022 Jan 10;40(1):3-5. doi: 10.1016/j.ccell.2021.11.006. Epub 2021 Nov 16. PMID: 34838186; PMCID: PMC8595142.
  10. Shastri A, Adrianzen-Herrera DA. Ruxolitinib in CMML: A Case Study of Innovative Trial Design in a Rare Cancer. Clin Cancer Res. 2021 Nov 15;27(22):6069-6071. doi: 10.1158/1078-0432.CCR-21-2578. Epub 2021 Sep 16. PMID: 34531297.
  11. Shapiro LC, Mustafa J, Lombardo A, Khatun F, Joseph F, Gillick K, Naik A, Elkind R, Abreu M, Fehn K, de Castro A, Pradhan K, Binakaj D, Nelson R, Paroder M, Uehlinger J, Gritsman K, Alejandro Sica R, Kornblum N, Shastri A, Mantzaris I, Bachier-Rodriguez L, Verma A, Braunschweig I, Goldfinger M. Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population. Bone Marrow Transplant. 2021 Jul;56(7):1761-1763. doi: 10.1038/s41409-021-01280-3. Epub 2021 Apr 12. PMID: 33846558.
  12. Zhang W, Acuna-Villaorduna A, Kuan K, Gupta S, Hu S, Ohaegbulam K, Albanese J, Kaumaya M, Levy R, Hwang RR, Zang X, Lin J, Liu Q, Maitra R, Goel S. B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal Cancer. Clin Colorectal Cancer. 2021 Jun;20(2):161-169. doi: 10.1016/j.clcc.2021.02.002. Epub 2021 Feb 19. PMID: 33745842.
  13. Thakkar A, Cui Z, Peeke SZ, Shah N, Pradhan K, Lombardo A, Khatun F, Mustafa J, De Castro A, Gillick K, Joseph F, Naik A, Rahman S, D'Aiello A, Elkind R, Sakalian S, Fehn K, Wright K, Abreu M, Townsend-Nugent L, Chambers N, Mathew R, Binakaj D, Nelson R, Palesi C, Paroder M, Uehlinger J, Wang Y, Shi Y, Zang X, Wang H, Nishimura C, Ren X, Steidl UG, Gritsman K, Janakiram M, Kornblum N, Derman O, Mantzaris I, Shastri A, Bartash R, Puius Y, McCort M, Goldfinger M, Bachier-Rodriguez L, Verma A, Braunschweig I, Sica RA. Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting. Stem Cell Investig. 2021 Sep 6;8:18. doi: 10.21037/sci-2021-008. PMID: 34631871; PMCID: PMC8449156.
  14. Lee M, Quinn R, Pradhan K, Fedorov K, Levitz D, Fromowitz A, Thakkar A, Shapiro LC, Kabarriti R, Ruiz RE, Andrews EM, Thota R, Chu E, Kalnicki S, Goldstein Y, Loeb D, Racine A, Halmos B, Mehta V, Verma A. Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave. Cancer Cell. 2022 Apr 11;40(4):343-345. doi: 10.1016/j.ccell.2022.02.012. Epub 2022 Feb 22. PMID: 35219358; PMCID: PMC8860706.
  15. Kim SY, Maitra R, Goel S. Multimodal immune activation abilities and characteristics of reovirus. Am J Transl Res. 2021 Dec 15;13(12):14176-14185. PMID: 35035763; PMCID: PMC8748157.
  16. Schmidt AL, Labaki C, Hsu CY, Bakouny Z, Balanchivadze N, Berg SA, Blau S, Daher A, El Zarif T, Friese CR, Griffiths EA, Hawley JE, Hayes-Lattin B, Karivedu V, Latif T, Mavromatis BH, McKay RR, Nagaraj G, Nguyen RH, Panagiotou OA, Portuguese AJ, Puc M, Santos Dutra M, Schroeder BA, Thakkar A, Wulff-Burchfield EM, Mishra S, Farmakiotis D, Shyr Y, Warner JL, Choueiri TK; COVID-19 and Cancer Consortium. COVID-19 vaccination and breakthrough infections in patients with cancer. Ann Oncol. 2022 Mar;33(3):340-346. doi: 10.1016/j.annonc.2021.12.006. Epub 2021 Dec 24. PMID: 34958894; PMCID: PMC8704021.
  17. Rahman S, Garrel S, Gerber M, Maitra R, Goel S. Therapeutic Targets of KRAS in Colorectal Cancer. Cancers (Basel). 2021 Dec 11;13(24):6233. doi: 10.3390/cancers13246233. PMID: 34944853; PMCID: PMC8699097.
  18. Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, Imaizumi Y, Watanabe M, Saito Y, Ito Y, McClure MB, Tabata M, Shingaki S, Yoshifuji K, Chiba K, Okada A, Kakiuchi N, Nannya Y, Kamiunten A, Tahira Y, Akizuki K, Sekine M, Shide K, Hidaka T, Kubuki Y, Kitanaka A, Hidaka M, Nakano N, Utsunomiya A, Sica RA, Acuna-Villaorduna A, Janakiram M, Shah U, Ramos JC, Shibata T, Takeuchi K, Takaori-Kondo A, Miyazaki Y, Matsuoka M, Ishitsuka K, Shiraishi Y, Miyano S, Ogawa S, Ye BH, Shimoda K, Kataoka K. Whole-genome landscape of adult T-cell leukemia/lymphoma. Blood. 2022 Feb 17;139(7):967-982. doi: 10.1182/blood.2021013568. PMID: 34695199; PMCID: PMC8854674.
  19. Lee M, Patel D, Jofre S, Fidvi S, Suhrland M, Cohen P, Cheng H. Large Cell Neuroendocrine Carcinoma Transformation as a Mechanism of Acquired Resistance to Osimertinib in Non-small Cell Lung Cancer: Case Report and Literature Review. Clin Lung Cancer. 2021 Aug 10:S1525-7304(21)00206-0. doi: 10.1016/j.cllc.2021.08.002. Epub ahead of print. PMID: 34535400.
  20. Fedorov K, Goel S, Kushnir M, Billett HH. Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists. Res Pract Thromb Haemost. 2021 Sep 14;5(6):e12574. doi: 10.1002/rth2.12574. PMID: 34532628; PMCID: PMC8440942.
  21. Thakkar A, Mishra S, Warner JL. COVID-19 Vaccine Among Actively-Treated People With Cancer: A Glimpse Into the Known Unknowns? J Natl Cancer Inst. 2022 Feb 7;114(2):169-171. doi: 10.1093/jnci/djab175. PMID: 34453849; PMCID: PMC8826529.

Take the Hematology-Oncology Fellowship Program Virtual Tour

See why so many applicants choose Montefiore-Einstein